This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Aichi Medical University, Knc Laboratories Co., Ltd., Nagoya Industrial Science Research Institute. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 6 
1 out of 11 
1 out of 35 
Years Active: 2010-2026
Title: Innovations by Gen Sobue: Pioneering Research in Antisense Oligonucleotides and Muscular Atrophy Treatments
Introduction
Gen Sobue is a notable inventor based in Nagoya, Japan, recognized for his contributions to the field of medical research. He holds two patents that focus on innovative treatments for spinal and bulbar muscular atrophy, as well as advancements in antisense oligonucleotide technology. His work has significant implications for understanding and treating neurodegenerative diseases.
Latest Patents
Sobue's latest patents include an antisense oligonucleotide designed to control the expression amount of TDP-43. This invention provides a suppression type antisense oligonucleotide targeting TDP-43 mRNA, which contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in specific nucleotide sequences. Additionally, he has developed methods for treating spinal and bulbar muscular atrophy using LHRH analogs. This patent outlines a model animal that faithfully reproduces the pathogenic conditions of the disease, facilitating the screening of potential remedies.
Career Highlights
Throughout his career, Gen Sobue has worked with esteemed institutions such as Osaka University and Knc Laboratories Co., Ltd. His research has contributed to a deeper understanding of muscular atrophy and the development of therapeutic strategies. Sobue's innovative approach has positioned him as a key figure in the field of medical research.
Collaborations
Gen Sobue has collaborated with notable colleagues, including Yoshitaka Nagai and Kazuhiro Maeta. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in the understanding of neurodegenerative diseases.
Conclusion
Gen Sobue's work exemplifies the intersection of innovation and medical research. His patents and collaborations reflect a commitment to advancing treatments for debilitating conditions. Sobue's contributions continue to inspire future research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile